BIO-RAD LABORATORIES, INC. — Director's Dealing 2011

Dec 16, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2011-12-14

Reporting Person: WADLER SANFORD (VP, General Counsel, Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-14	Bio-Rad A Common Stock	M	1000	$62.47	Acquired	12936	Direct
2011-12-14	Bio-Rad A Common Stock	M	600	$75.32	Acquired	13536	Direct
2011-12-14	Bio-Rad A Common Stock	M	1200	$74.27	Acquired	14736	Direct
2011-12-14	Bio-Rad A Common Stock	S	1000	$89.05	Disposed	13736	Direct
2011-12-14	Bio-Rad A Common Stock	S	600	$89.05	Disposed	13136	Direct
2011-12-14	Bio-Rad A Common Stock	S	1200	$89.05	Disposed	11936	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-14	Incentive Stock Option (right to buy)	$62.47	M	1000	Disposed	2016-04-03	Bio-Rad A Common Stock (1000)	Direct
2011-12-14	Non-Qualified Stock Option (right to buy)	$75.32	M	600	Disposed	2017-08-01	Bio-Rad A Common Stock (600)	Direct
2011-12-14	Non-Qualified Stock Option (right to buy)	$74.27	M	1200	Disposed	2019-06-10	Bio-Rad A Common Stock (1200)	Direct

Footnotes

F1: The stock option vested in five equal annual installments beginning on April 3, 2007

F2: The stock option vests in five equal annual installments beginning on August 1, 2008

F3: The stock option vests in five equal annual installments beginning on June 10, 2010

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.00 to $89.16, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.